TY - JOUR
T1 - Hair cortisol as a biomarker of stress among a First Nation in Canada
AU - Henley, Phaedra
AU - Jahedmotlagh, Zahra
AU - Thomson, Steven
AU - Hill, Julie
AU - Darnell, Regna
AU - Jacobs, Dean
AU - Johnson, Joyce
AU - Williams, Naomi C.
AU - Williams, Rosemary M.
AU - Van Uum, Stan
AU - Bend, John R.
AU - Koren, Gideon
PY - 2013/10
Y1 - 2013/10
N2 - BACKGROUND:: Cortisol level in hair is increasingly being used as a biomarker of chronic stress. Members of First Nation communities in Canada are experiencing stress related to a higher incidence of chronic diseases, socioeconomic factors, the state of their environment, and cultural oppression. This study aimed to investigate hair cortisol as a biomarker of stress in this population. MATERIALS AND METHODS:: Hair samples were collected from the posterior vertex of 55 Walpole Island First Nation (WIFN) volunteers and compared with white volunteers living in and around London, ON, Canada. An enzyme-linked immunosorbent assay technique was used to measure cortisol content in 1 cm of hair, considered to represent 1 month of growth. In parallel, the Perceived Stress Scale (PSS), which measures short-term stress, was also completed. RESULTS:: Median hair cortisol level (range) in WIFN volunteers was 177 (93-273) ng/g, significantly higher than the median hair cortisol in the healthy white controls of 116 (26-204) ng/g (P < 0.0001, Mann-Whitney U test). Hair cortisol correlated positively with gender, smoking status, and self-reported diabetes. Unlike hair cortisol, the Perceived Stress Scale did not differentiate between the First Nation and control population. CONCLUSIONS:: The increased hair cortisol concentrations among WIFN volunteers compared with volunteers from a non-First Nation community suggests higher levels of chronic stress. The causes for this apparent increased stress are likely due to factors such as socioeconomic and poorer health and are worthy of further evaluation. The results highlight the difference between acute stress measured for short periods of time compared with chronic stress, measured by hair analysis.
AB - BACKGROUND:: Cortisol level in hair is increasingly being used as a biomarker of chronic stress. Members of First Nation communities in Canada are experiencing stress related to a higher incidence of chronic diseases, socioeconomic factors, the state of their environment, and cultural oppression. This study aimed to investigate hair cortisol as a biomarker of stress in this population. MATERIALS AND METHODS:: Hair samples were collected from the posterior vertex of 55 Walpole Island First Nation (WIFN) volunteers and compared with white volunteers living in and around London, ON, Canada. An enzyme-linked immunosorbent assay technique was used to measure cortisol content in 1 cm of hair, considered to represent 1 month of growth. In parallel, the Perceived Stress Scale (PSS), which measures short-term stress, was also completed. RESULTS:: Median hair cortisol level (range) in WIFN volunteers was 177 (93-273) ng/g, significantly higher than the median hair cortisol in the healthy white controls of 116 (26-204) ng/g (P < 0.0001, Mann-Whitney U test). Hair cortisol correlated positively with gender, smoking status, and self-reported diabetes. Unlike hair cortisol, the Perceived Stress Scale did not differentiate between the First Nation and control population. CONCLUSIONS:: The increased hair cortisol concentrations among WIFN volunteers compared with volunteers from a non-First Nation community suggests higher levels of chronic stress. The causes for this apparent increased stress are likely due to factors such as socioeconomic and poorer health and are worthy of further evaluation. The results highlight the difference between acute stress measured for short periods of time compared with chronic stress, measured by hair analysis.
KW - First Nations
KW - chronic stress
KW - cortisol
KW - diabetes mellitus
KW - hair
KW - smoking
UR - http://www.scopus.com/inward/record.url?scp=84885009259&partnerID=8YFLogxK
U2 - 10.1097/FTD.0b013e318292eb84
DO - 10.1097/FTD.0b013e318292eb84
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 24052063
AN - SCOPUS:84885009259
SN - 0163-4356
VL - 35
SP - 595
EP - 599
JO - Therapeutic Drug Monitoring
JF - Therapeutic Drug Monitoring
IS - 5
ER -